OVS (OVS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Q1 2024 net sales reached €352.2 million, up 5% year-over-year, with strong growth across all main brands and channels, especially Upim, despite supply chain disruptions and adverse weather.
Adjusted EBITDA rose 8.1% to €29.7 million, with margin improving to 8.4% from 8.2% in Q1 2023.
Adjusted profit before tax increased 31.1% to €10.1 million, with operating leverage and stable D&A and interest costs.
Net cash flow improved by €3.5 million year-over-year, despite €20.6 million in treasury share purchases and €7.8 million in dividends.
Brand momentum remains strong, with positive like-for-like sales and robust sales momentum into the current period, despite external disruptions.
Financial highlights
Net sales: €352.2 million (+5% vs. Q1 2023); Adjusted EBITDA: €29.7 million (+8.1%); Adjusted EBIT: €14.2 million (+21.2%).
EBITDA margin increased to 8.4%; EBIT margin rose to 4.0% from 3.5% year-over-year.
Trade working capital improved by €18.2 million year-over-year, driven by inventory reduction and higher trade payables.
Directly operated stores drove a 5.1% sales increase; franchise channel sales grew 3.2% after a prior year decline.
Trade receivables rose 3% in line with sales; inventory reduced by €5 million due to clearance of previous season stock.
Outlook and guidance
Sales trend remains robust into Q2 and full-year 2024, with continued sales growth and further gross margin improvement expected as supply chain normalizes.
2024 expected to benefit from normalization of product costs and renewed labor contracts with diluted impact over several years.
Year-to-date sales are up mid-single digits versus 2023; full-year improvement anticipated.
Latest events from OVS
- Sales and margins rose in H1 2024, with strong September momentum and positive outlook.OVS
Q2 202520 Jan 2026 - Q3 2024 delivered double-digit sales and EBITDA growth, with robust outlook and share buybacks.OVS
Q3 202511 Jan 2026 - Sales up 6.2%, margins and cash flow improved, with higher dividend and buyback ahead.OVS
Q4 202523 Dec 2025 - Sales and EBITDA up, leverage improved, and outlook remains positive for year-end.OVS
Q3 202618 Dec 2025 - Record sales and profit growth in 1H 2025, with strong outlook and Goldenpoint boost.OVS
Q2 202616 Dec 2025 - Q1 sales grew 0.6% to €354.4m; Goldenpoint synergies and Q2 momentum support a positive outlook.OVS
Q1 202614 Nov 2025